AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2019
Jan 4, 2019
35119_dirs_2019-01-04_c5343c6f-522d-4230-8c28-cbc4e15aef46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2019-01-02
Reporting Person: SCHABER CHRISTOPHER J (Chairman, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-02 | Option (Right to Buy) | $0.96 | A | 60000 | Acquired | 2029-01-01 | Common Stock (60000) | Direct |
Footnotes
F1: The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of January 2, 2019. The stock option was granted to address equity inadequacies revealed by independent external review among other reasons determined to be relevant by the Issuer's board of directors.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3